首页 > 肿瘤 > 肿瘤 > 

151.[学科动态]肿瘤治疗新途径 曲线超声内镜注射药物
152.[临床实践]Prognostic value of lymph node metastases and lymph node ratio in esophageal squamous cell carcinoma
153.[临床试验]PPO基因在多种良性恶性肿瘤表达的初步研究
154.[临床实践]COX-2启动子区单核苷酸多态与胰腺癌
155.[临床试验]上海女性月经生育模式的变化及对乳腺癌发生趋势的影响
156.[产品动态]Phosphocol可增加恶性肿瘤风险和造成放射损伤
157.[产品动态]美国FDA批准Sancuso治疗化疗所致恶心呕吐
158.[专家讲座]Laparoscopic or thoracoscopic surgery – does it reduce the morbidity of esophagectomy?
159.[专家讲座]PRIMARY PREVENTION IN CANCER CONTROL
160.[专家讲座]PRIMARY AND SECONDARY PREVENTION OF CANCER
161.[专家讲座]Molecular Imaging Diagnostics in Oncology
162.[专家讲座]METABOLIC SYNDROME ,OBESITY AND CANCER
163.[专家讲座]Genetic Prevention in Breast and Ovarian Cancer
164.[专家讲座]Reducing the burden of cancer in populations through behavior change and public policy
165.[专家讲座]Pancreatic Cancer Translational Research---Searching for new tumor vaccines, biomarkers and therapeutic targets
166.[临床实践]P53: a heavily dictated “dictator” of life and death （摘要）
167.[临床实践]Enabling RNAi therapeutics the non-viral nanotechnology way（摘要）
168.[临床试验]Lentiviral vectors as vaccines（摘要）
169.[临床实践]Listeria Monocytogenes Mediated Gene Delivery: A Novel Non-Viral Gene Delivery Strategy With Replication And Local Spreading Ability, Conferring Efficient Long-Term Gene Expression In Tumours
170.[临床试验]Combinatory use of adenoviruses-mediated cell death, chemotherapeutic agents and a novel interferon
171.[临床试验]Novel molecular targets involved in the regulation of epidermal growth factor receptor (EGFR) in head and neck cancers
172.[临床实践]Develop monoclonal antibody to OX40 to shut down regulatory T cell function in tumors and to enhance anti-tumor immune responses
173.[临床实践]Systemic Delivery of Oncolytic Viruses
174.[临床试验]Functional Effect of Acid Ceramidase Reveals a Novel Target for Prostates Cancer Therapy(摘要)
175.[临床试验]Immune gene therapy for Acute Myeloid Leukaemia (AML): a Phase-I clinical trial（摘要）
176.[临床试验]Targeting Human Mesenchymal Stem Cells to Treat Experimental Glioma（摘要）
177.[临床实践]Expression Levels of the Leukaemia Associated Antigen SSX2IP is a Biomarker for Survival (摘要)
178.[临床实践]Regulatory T cells and Toll-like receptor signalling in cancer therapy（摘要）
179.[临床实践]Regulation of Antigen Presentation and Tumor Vaccines（摘要）
180.[临床试验]Molecular oncology: pursuing targets of cancer prevention and therapy